ArticleThe Journal of clinical and aesthetic dermatology2020

Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea.

Linda Stein Gold et al.PubMed ↗Full text ↗

No numbers read from the abstract.